We’re pleased to announce that we are currently recruiting patients for CARE NSW, a large-scale clinical trial measuring the control of symptoms in people with advanced cancer by cannabis medicines.
Chris O’Brien Lifehouse oncologists A/Prof Judith Lacey and A/Prof Peter Grimison are co-investigators on the trial, led by the Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), a National Health and Medical Research Council Centre of Research Excellence.
CARE NSW is a state-wide study, supported by NSW Health through the NSW Clinical Cannabis Medicines Program, which will collect information to guide the future use of cannabis medicines in people living with advanced cancer, including finding the best dose to use for successful symptom control.
Judith says, “This trial is a valuable opportunity to develop evidence to support the safe and effective use of cannabis medicines for patients with advanced cancer.”
Eligible participants will receive cannabis medicines that may help relieve symptoms of advanced cancer including, loss of appetite, pain that doesn’t respond well to other medicines, and nausea. Patients will be screened before being admitted to the trial to ensure that it is safe and appropriate for them to participate.
The CARE NSW Trial will contribute to a greater understanding of the efficacy, tolerability and safety of cannabis medicines as well as understanding its potential benefits to patients’ quality of life.